Omni Bio Pharmaceutical Inc (OMBP) financial statements (2020 and earlier)

Company profile

Business Address 181 W BOARDWALK DRIVE
FORT COLLINS, CO 80525
State of Incorp. CO
Fiscal Year End March 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments271343
Cash and cash equivalents271343
Other current assets3242
Total current assets:304385
Noncurrent Assets
Intangible assets, net (including goodwill)6368
Intangible assets, net (excluding goodwill)6368
Regulated entity, other noncurrent assets130246
Total noncurrent assets:193314
TOTAL ASSETS:497699
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities96124
Accounts payable943
Accrued liabilities8881
Total current liabilities:96124
Noncurrent Liabilities
Long-term debt and lease obligation282227
Long-term debt, excluding current maturities282227
Other undisclosed noncurrent liabilities1,003953
Total noncurrent liabilities:1,2851,180
Total liabilities:1,3811,304
Stockholders' equity
Stockholders' equity attributable to parent, including:(884)(605)
Common stock3932
Additional paid in capital45,60943,378
Accumulated deficit (44,015)
Other undisclosed stockholders' equity attributable to parent(46,532) 
Total stockholders' equity:(884)(605)
TOTAL LIABILITIES AND EQUITY:497699

Income statement (P&L) ($ in thousands)

3/31/2014
3/31/2013
Operating expenses(1,912)(5,720)
Other undisclosed operating loss (31)
Operating loss:(1,912)(5,720)
Nonoperating expense(604)(1,734)
Loss from continuing operations before equity method investments, income taxes:(2,517)(7,455)
Loss from equity method investments (780)
Loss before gain (loss) on sale of properties:(2,517)(8,235)
Other undisclosed net income 780
Net loss available to common stockholders, diluted:(2,517)(7,455)

Comprehensive Income ($ in thousands)

3/31/2014
3/31/2013
Net loss:(2,517)(7,455)
Comprehensive loss, net of tax, attributable to parent:(2,517)(7,455)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: